XML 26 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:      
Net income (loss) $ (7,990) $ (35,412) $ 45,546
Loss from discontinued operations 0 3,847 6,461
Income (loss) from continuing operations (7,990) (31,565) 52,007
Adjustments to reconcile to net cash provided by operating activities:      
Depreciation and amortization 43,791 44,312 40,329
Gain on sale of fixed assets (929) (310) (816)
Equity-based compensation expense 7,987 5,073 5,647
Deferred income taxes 924 (16,816) (2,675)
Equity in earnings of affiliated companies 0 (570) (5,159)
Non-cash restructuring charges 1,816 20,592 0
Fixed asset impairment 0 11,870 0
Definite-lived intangible asset impairment 0 12,116 0
Goodwill impairment 43,484 51,512 0
Debt issuance costs 3,377 157 1,964
Earnout reversal 0 0 (4,175)
(Gain) loss on sale of businesses 3,414 988 (11,771)
Loss on foreign currency transactions 80 627 2,425
Other (168) 1,279 1,588
Changes in operating assets and liabilities (net of acquisitions):      
Restricted cash related to operating activities (382) (454) (102)
Return on equity of affiliated companies 0 590 10,691
Receivables net, retainage and costs and estimated earnings in excess of billings 12,283 (41,211) 8,222
Inventories 6,984 (5,286) (736)
Prepaid expenses and other assets (28,895) 3,465 (9,685)
Accounts payable and accrued expenses (582) 5,997 8,944
Billings in excess of costs and estimated earnings 45,700 19,100 (6,340)
Other operating 1,129 402 (2,293)
Net cash provided by operating activities of continuing operations 132,023 81,868 88,065
Net cash used in operating activities of discontinued operations 0 (1,045) (3,761)
Net cash provided by operating activities 132,023 80,823 84,304
Cash flows from investing activities:      
Capital expenditures (29,454) (32,899) (26,085)
Proceeds from sale of fixed assets 3,173 1,547 3,435
Patent expenditures (1,503) (1,923) (2,032)
Restricted cash related to investing activities (3,538) (1,153) 0
Purchase of Schultz Mechanical Contractors, Inc. (6,662) 0 0
Purchase of Fyfe Asia, net of cash acquired (1,098) 0 0
Purchase of Brinderson, net of cash acquired 0 1,000 (143,763)
Proceeds from sale of interests in Bayou Coating, L.L.C. 0 9,065 0
Proceeds from sale of Ka-te Insituform AG 0 1,123 0
Proceeds from sale of interests in German joint venture 0 0 18,300
Net cash used in investing activities of continuing operations (39,082) (23,240) (150,145)
Net cash provided by investing activities of discontinued operations 0 1,045 845
Net cash used in investing activities (39,082) (22,195) (149,300)
Cash flows from financing activities:      
Proceeds from issuance of common stock upon stock option exercises, including tax effects 2,466 8,615 594
Repurchase of common stock (27,804) (31,085) (27,648)
Sale of non-controlling interest 239 0 0
Purchase of or distributions to non-controlling interests (472) (617) (287)
Payment of earnout related to acquisition of CRTS, Inc. (684) 0 (2,112)
Credit facility financing fees (4,360) (783) (5,013)
Proceeds from notes payable 1,505 1,284 1,541
Principal payments on notes payable (1,875) 0 (183)
Proceeds from line of credit 26,000 18,000 0
Payments on line of credit (71,500) (8,000) 0
Proceeds from long-term debt 350,000 0 385,500
Principal payments on long-term debt (323,750) (22,039) (253,500)
Net cash provided by (used in) financing activities (50,235) (34,625) 98,892
Effect of exchange rate changes on cash (5,975) (7,083) (9,527)
Net increase in cash and cash equivalents for the year 36,731 16,920 24,369
Cash and cash equivalents, beginning of year 174,965 158,045 133,676
Cash and cash equivalents, end of year 211,696 174,965 158,045
Cash and cash equivalents associated with assets held for sale, end of year (2,443) 0 0
Cash and cash equivalents from continuing operations, end of year 209,253 174,965 158,045
Supplemental disclosures of cash flow information:      
Interest 9,873 9,602 8,700
Income taxes $ 8,753 $ 12,594 $ 11,630